Literature DB >> 15191801

Insulin as an in vivo growth factor.

Q-G Xu1, X-Q Li, S A Kotecha, C Cheng, H S Sun, D W Zochodne.   

Abstract

Insulin peptide has been identified to promote regeneration of axons in culture and in some in vivo model systems. Such actions have been linked to direct actions of insulin, or to cross occupation of closely linked IGF-1 receptors. In this work, we examined insulin support of peripheral nerve regenerative events in mice. Systemic insulin administration accelerated the reinnervation of foot interosseous endplates by motor axons after sciatic nerve transection and enhanced recovery of functional mouse hindpaw function. Similarly, insulin accelerated the regeneration-related maturation of myelinated fibers regrowing beyond a sciatic nerve crush injury. That such benefits might occur through direct signaling on axons was supported by immunohistochemical studies of expression with an antibody directed to the beta insulin receptor (IR) subunit. The proportion of sensory neurons expressing IRbeta increased ipsilateral to a similar sciatic crush injury in the L4 and L5 dorsal root ganglia. Insulin receptors, although widely expressed in axons, were also preferentially and intensely expressed on axons regrowing just beyond a peripheral nerve crush injury zone. The findings indicate that insulin imparts a substantial impact on regenerating peripheral nerve axons through upregulation of its expression following injury. Although the findings do not exclude insulin coactivating IGF-1 receptors during regeneration, its own receptors are present and available for action on injured nerves.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191801     DOI: 10.1016/j.expneurol.2004.03.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  32 in total

1.  In vivo peripheral nervous system insulin signaling.

Authors:  Caleb W Grote; Janelle M Ryals; Douglas E Wright
Journal:  J Peripher Nerv Syst       Date:  2013-09       Impact factor: 3.494

Review 2.  Routes for the delivery of insulin to the central nervous system: A comparative review.

Authors:  Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Neurol       Date:  2018-11-27       Impact factor: 5.330

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons.

Authors:  Bhumsoo Kim; Lisa L McLean; Stephen S Philip; Eva L Feldman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

Review 5.  Peripheral Neuropathy in Mouse Models of Diabetes.

Authors:  Corinne G Jolivalt; Katie E Frizzi; Lucie Guernsey; Alex Marquez; Joseline Ochoa; Maria Rodriguez; Nigel A Calcutt
Journal:  Curr Protoc Mouse Biol       Date:  2016-09-01

Review 6.  Insulin resistance in the nervous system.

Authors:  Bhumsoo Kim; Eva L Feldman
Journal:  Trends Endocrinol Metab       Date:  2012-01-13       Impact factor: 12.015

Review 7.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 8.  Epidermal nerve fiber quantification in the assessment of diabetic neuropathy.

Authors:  Kristina K Beiswenger; Nigel A Calcutt; Andrew P Mizisin
Journal:  Acta Histochem       Date:  2008-04-01       Impact factor: 2.479

9.  Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.

Authors:  James W Russell; Alison Berent-Spillson; Andrea M Vincent; Catherine L Freimann; Kelli A Sullivan; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2008-03-15       Impact factor: 5.996

10.  Intranasal insulin ameliorates experimental diabetic neuropathy.

Authors:  George Francis; Jose Martinez; Wei Liu; Thuhien Nguyen; Amit Ayer; Jared Fine; Douglas Zochodne; Leah R Hanson; William H Frey; Cory Toth
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.